Catalyst Pharmaceuticals (CPRX) Other Operating Expenses (2019 - 2026)

Catalyst Pharmaceuticals (CPRX) has 8 years of Other Operating Expenses data on file, last reported at $24.2 million in Q1 2026.

• For the quarter ending Q1 2026, Other Operating Expenses fell 11.29% year-over-year to $24.2 million; the trailing twelve-month figure through Mar 2026 stood at $121.7 million (up 9.01% YoY), and the FY2025 full-year result was $124.8 million, up 17.44% from the prior year.
• Other Operating Expenses for Q1 2026 stood at $24.2 million, down from $35.5 million in the prior quarter.
• Across five years, Other Operating Expenses topped out at $35.5 million in Q4 2025 and bottomed at $5.9 million in Q1 2022.
• The 5-year median for Other Operating Expenses is $24.2 million (2026), against an average of $22.1 million.
• The widest annual swing landed in 2023, when Other Operating Expenses soared 179.75%; it then fell 11.29% in 2026.
• A 5-year view of Other Operating Expenses shows it stood at $11.8 million in 2022, then soared by 111.19% to $24.9 million in 2023, then climbed by 24.61% to $31.0 million in 2024, then rose by 14.69% to $35.5 million in 2025, then plunged by 31.97% to $24.2 million in 2026.
• The last three Other Operating Expenses figures came in at $24.2 million (Q1 2026), $35.5 million (Q4 2025), and $32.0 million (Q3 2025), per Business Quant data.

Peer Comparison